AboutCOVID-19Careers in pharmacologyNewsEventsEducation & engagementPartner with UsPublishingMembership & awardsMy BPS & resources

Reversible posterior leukoencephalopathy syndrome associated with bevacizumab/doxorubicin regimen

Article date: May 2008

By: Franck Bürki, Kattalin Badie, Philippe Bartoli, Pascale Bernard, Jean Louis Montastruc, Haleh Bagheri, in Volume 65, Issue 5, pages 793-794

DOI: 10.1111/j.1365-2125.2008.03119.x

View this article

Publishing

Contact us

About this website

Become a member

BPS Assessment Ltd

BPS on LinkedIn BPS on Bluesky BPS on Facebook BPS on Instagram BPS on Reddit BPS on ThreadsBPS on YouTube

British Pharmacological Society is a registered UK charity - Charity No. 1030623. It is also a company limited by guarantee registered in England and Wales - Company Number 2877400.
Its registered office is The Schild Plot, 16 Angel Gate, City Road, London, EC1V 2PT, United Kingdom

© 2025 British Pharmacological Society. All rights reserved.